New 'Living Drug' trial aims to tame rogue immune system
Disease control
Not yet recruiting
This is an early-stage study to test the safety and initial effects of a new cell therapy called BEN301 Injection for people with certain autoimmune diseases. The therapy involves modifying a patient's own immune cells (called CAR-Tregs) to try to calm down the overactive immune …
Phase: EARLY_PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC